|
| |
| | | 65809 | | 19.05.2015 | | Mepha Pharma AG | | | | | | | | | | | | | 01.01.30. | | | | 01.01.30. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Buprenorphin-Mepha 35ug/h | Transdermale Pflaster | (Buprenorphinum 20 mg) | N02AE01 | PI | | 02 | Buprenorphin-Mepha 52.5 ug/h | Transdermale Pflaster | (Buprenorphinum 30 mg) | N02AE01 | PI | | 03 | Buprenorphin-Mepha 70 ug/h | Transdermale Pflaster | (Buprenorphinum 40 mg) | N02AE01 | PI |
|
|
|
